SCHEMBL878992

SCHEMBL878992

OCC1CC2C3CCC(C3)C2C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.34
APLNR P35414 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17772497 0.82
SCHEMBL16229273 0.82
SCHEMBL7092456 0.77 NR1H2 (0.32)
SCHEMBL31498834 0.76
SCHEMBL23718855 0.75
SCHEMBL14463201 0.75
SCHEMBL10176224 0.75 EPHX2 (0.31) EPHX2
SCHEMBL16449084 0.72
SCHEMBL13892516 0.72 NR1H2 (0.37) EPHX2APLNR
SCHEMBL24981741 0.72 EPHX2 (0.34) EPHX2APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12013523-B2 Immersion oils having long service life CARL ZEISS JENA GMBH (DE) 2024-06-18 US claimed
US-20250186646-A1 Use of Volatile Compositions to Limit or Eliminate Perception of Fecal Malodour FIRMENICH SA (CH) 2025-06-12 US disclosed
US-12013523-B2 Immersion oils having long service life CARL ZEISS JENA GMBH (DE) 2024-06-18 US disclosed
US-11744785-B2 Use of volatile compositions to limit or eliminate the perception of malodor FIRMENICH SA (CH) 2023-09-05 US disclosed
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2023-07-27 US disclosed
US-20210302712-A1 Immersion oils having long service life CARL ZEISS JENA GMBH (DE) 2021-09-30 US disclosed
US-20200345601-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2020-11-05 US disclosed
US-20190343977-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR FIRMENICH SA (CH) 2019-11-14 US disclosed
EP-1489459-B1 Positive resist composition and method of forming pattern using the same FUJIFILM CORP (JP) 2015-10-14 EP disclosed
EP-2009304-B1 TORQUE LIMITER JTEKT CORP (JP) 2014-10-01 EP disclosed
US-7235341-B2 Positive resist composition FUJIFILM CORPORATION (JP) 2007-06-26 US disclosed
US-20070141513-A1 Positive photosensitive composition FUJI PHOTO FILM CO., LTD. 2007-06-21 US disclosed
US-20070141513-A1 Positive photosensitive composition FUJI PHOTO FILM CO., LTD. 2007-06-21 US disclosed
US-7214465-B2 Positive photosensitive composition FUJIFILM CORPORATION (JP) 2007-05-08 US disclosed
US-7214465-B2 Positive photosensitive composition FUJIFILM CORPORATION (JP) 2007-05-08 US disclosed
US-7192681-B2 Positive photosensitive composition FUJI PHOTO FILM CO., LTD. (JP) 2007-03-20 US disclosed
US-7192681-B2 Positive photosensitive composition FUJI PHOTO FILM CO., LTD. (JP) 2007-03-20 US disclosed
EP-0292215-B2 Method for production of methacrylate ester HITACHI CHEMICAL CO LTD (JP) 1997-10-08 EP disclosed
EP-0292215-A2 Method for production of methacrylate ester Hitachi Chemical Co., Ltd. (JP) 1988-11-23 EP disclosed
EP-0171847-B1 LIQUID, CURABLE COATING COMPOSITION BASED ON A HYDROXYL GROUPS-CONTAINING ADDITION POLYMER AS BINDER AKZO N.V. (NL) 1988-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12013523-B2 Immersion oils having long service life DGKI, CCNE2, CYCS EPHX2 1169/4885APLNR 1368/4885
US-11744785-B2 Use of volatile compositions to limit or eliminate the perception of malodor TAS2R8, TRPA1, TAS2R10 EPHX2 1465/4885APLNR 2186/4885
US-20200345601-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 EPHX2 1465/4885APLNR 2186/4885
US-20210302712-A1 Immersion oils having long service life DGKI, CCNE2, CYCS EPHX2 1169/4885APLNR 1368/4885
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 EPHX2 1465/4885APLNR 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.